🔗 Share this article

Treasury head Reeves has announced she is preparing "specific measures to address cost of living issues" in the forthcoming financial statement.

Speaking to media outlets, she emphasized that curbing price rises is a joint duty of both the government and the Bank of England.

The UK's price growth is forecast to be the most elevated among the Group of Seven developed nations this calendar year and the following year.

Potential Utility Bill Measures

Sources suggest the government could intervene to lower energy bills, for example by slashing the current 5% rate of value-added tax applied on energy supplies.

Another possibility is to cut some of the government charges presently included in bills.

Budgetary Limitations and Analyst Expectations

The government will receive the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much room there is for these actions.

The view from the majority of economists is that Reeves will have to declare tax increases or spending cuts in order to meet her declared borrowing rules.

Previously on the same day, calculations suggested there was a £22bn deficit for the chancellor to fill, which is at the lower end of expectations.

"There's a joint job between the central bank and the administration to further reduce some of the causes of inflation," Reeves informed reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and International Concerns

While a great deal of the focus has been on probable tax rises, the chancellor said the most recent data from the OBR had not altered her vow to campaign commitments not to raise tax levels on income tax, VAT or National Insurance.

She blamed an "unpredictable global environment" with increasing geopolitical and commercial tensions for the Budget revenue measures, probably to be focused on those "with the broadest shoulders."

Global Economic Disputes

Commenting on apprehensions about the UK's economic relations with the Asian nation she said: "The UK's national security invariably take priority."

Last week's declaration by Chinese authorities to tighten trade restrictions on critical minerals and other materials that are crucial for advanced tech production led American leader the US President to threaten an extra 100% tariff on imports from the Asian country, increasing the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary labeled the Chinese decision "economic coercion" and "a global supply chain power grab."

Inquired about considering the American proposal to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "bad for the international commerce and generates additional challenges."

"It is my opinion there are areas where we need to confront Chinese policies, but there are also important opportunities to export to Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that balance right."

The Treasury chief also stated she was cooperating with other major economies "on our own essential resources approach, so that we are more independent."

NHS Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the NHS spends on drugs could go up as a consequence of current discussions with the US government and its pharmaceutical firms, in return for reduced taxes and funding.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or abandoning projects in the United Kingdom, with several attributing the low prices they are getting.

Recently, the government science advisor said the cost the health service spends on drugs would must rise to stop businesses and drug research funding leaving the United Kingdom.

The Chancellor stated to the BBC: "It has been observed due to the pricing regime, that medical research, new drugs have not been provided in the UK in the extent that they are in other EU nations."

"We want to make sure that individuals receiving treatment from the National Health Service are able to obtain the best critical medicines in the world. And so we are looking at this situation, and... aiming to obtain additional capital into the UK."